Annals of the Rheumatic Diseases | ARD is an international peer-reviewed journal covering all aspects of rheumatology, including musculoskeletal conditions, arthritic disease and connective tissue disorders.

Intro Widget

Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal covering all aspects of rheumatology, which includes the full spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research, including the most important recommendations for the management of various conditions.

ARD is an official journal of EULAR.

Free lay summaries are provided for selected research articles. You can keep up with the latest news via Twitter and Facebook.

Editor-in-Chief: Professor Josef Smolen, Medical University of Vienna, Austria
Editorial team

Impact Factor: 12.350

Authors

Annals of the Rheumatic Diseases considers unsolicited submissions of a variety of article types, including original research articles (extended and concise reports), viewpoints, and letters to the Editor.

The Author Information section provides general guidelines and requirements for specific article types.

Information is also provided on editorial policies and open access.

Impact Factor: 12.350

Author information

Submit a paper

Intro Widget

Latest Articles

Correspondence:

Changing landscape of immunosuppression in ANCA-associated vasculitis

Rheumatoid arthritis:

Prevotella copri in individuals at risk for rheumatoid arthritis

Letter:

Reproductive health outcomes in women with psoriatic arthritis

Letter:

Association of MUC5B promoter polymorphism with interstitial lung disease in myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis

Correspondence response:

Response to ‘Everything we see is a perspective, not the truth’ by Chattopadhyay et al

Editor’s Choice

Systemic lupus erythematosus:

Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity

Vasculitis:

Cardiovascular, thromboembolic and renal outcomes in IgA vasculitis (Henoch-Schönlein purpura): a retrospective cohort study using routinely collected primary care data

Clinical and epidemiological research:

Tocilizumab in patients with adult-onset still’s disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial

Criteria:

Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study

Review:

Gene editing for inflammatory disorders

Related Journals

Most Read Articles

Recommendation:

2018 update of the EULAR recommendations for the management of Behçet’s syndrome

Rheumatoid arthritis:

Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study

Systemic lupus erythematosus:

Organ damage in patients treated with belimumab versus standard of care: a propensity score-matched comparative analysis

Recommendation:

2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis

Recommendation:

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)–Pan-American League of Associations of Rheumatology (PANLAR)

Authors